Paraoxonase activity in type 2 diabetes mellitus patients with and without complications

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 1, 2011, Pages 63-65

  Suvarna, Renuka ^a   Rao, Soumya S ^a   Joshi, Chitralekha ^a   Kedage, Vivekananda ^a   Muttigi, Manjunatha S ^a   Shetty, Jeevan K ^a   Prakash, Mungli ^b  

^a KASTURBA MEDICAL COLLEGE   (India)

^b St Matthew's University School of Medicine   (Cayman Islands)

Author keywords

Anti atherogenesis; Diabetes; Fasting lipid profile; PON1

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79952681084     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after thirty five years. Diabete Metab Rev 1998; 14: 263-283.
2. Chait A, Brazg R, Tribble D, Krauss R. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med. 1993; 94: 350-356.
3. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 1991; 86: 193-199.
4. Abbott CA, Mackness MI, Kumar S, Boulton AJM, Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol. 1995; 15: 1812-1818.
5. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuashia B, Miller JE, Boulton AJM, Durrington PN. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis. 1998; 139: 341-349.
6. Mackness B, Durrington PN, Abuashia B, Boulton AJM, Mackness MI. Low paraoxonase activity in type II diabetes complicated by retinopathy. Clin Sci. 2000; 98: 355-363.
7. Primo-Parma SL, Sorenson RC, Teiber J, La Du BN. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 1996; 33: 498-509.
8. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 1996; 7: 69-76.
9. Durrington P N, Mackness B, Mackness M I. Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2001; 21: 473.
10. Schiavon R, De Fanti E, Giavarina D, Biasioli S, Cavalcanti G, Guidi G. Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta 1996; 247: 71-80.
11. Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969 Mar; 22(2):158-161.
12. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total cholesterol. Clin Chem 1974; 20(6):470-75.
13. McGowan MW. An improved enzymatic method for determination of blood triglycerides by oxidase system. Clin Chem 1983 97:142-144.
14. Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma,without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
15. Kalousova M, Krha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002; 51: 597-604.